Once this science reaches the marketable stage of development, it won't matter if George Kostanza was running the company. Look at Ichim's previous accomplishments and understand what a lot of savvy investors are posting on these boards instead of knocking yourself around in your head all the time, Biotech investing is a tough endeavor.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.